NEWS 

2021.01.25 Dr.Kawamoto and Dr.Tanaka will give a lecture at the iForum ™ 2021 Virtual User Group Meeting on January 28th.
   
   
2021.01.08 Axcelead's response to the COVID-19 emergency declaration in January 2021
   
   
2020.12.10 Evommune and Axcelead Drug Discovery Partners Launch A Collaboration On A PKCtheta Program To Kick-off Evommune’s Inflammation Pipeline
   
   
2020.10.02 Axcelead and Kyowa Kirin Started an Innovative Collaboration in Small-Molecule Drug Development
   
   
2020.6.29 Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
   
   
2019.10.01 PassPort Technologies and Axcelead contribute to maximizing R&D pipeline value though providing a new modality
   
   
2019.07.10 Fujifilm and Axcelead Drug Discovery Partners begin collaborating to advance drug discovery solutions using iPSCs
   
   
2019.04.01 Transfer of All Axcelead Shares to Whiz Partners DDG Fund Completed
   
   
2018.10.04 Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
   
   
2018.09.28 This website has been renewed
   
   
2018.08.03 Announcement on starting preparation to become a company independent from Takeda
   
   
2018.05.30 Announcement of Start of Business Partnership between Axcelead and LAP&P for Modeling and Simulation of Drug Discovery
   
   
2017.10.16 Axcelead exhibited at Bio Japan 2017 and Japan Healthcare Venture Summit 2017
   
   
2017.09.15 AMED adopted Axcelead as "Innovation Engine Unit" under Grant Programme "Project Promoting Support for Drug Discovery FY2017".
   
   
2017.07.10 Takeda Announces the Start of Operations for Axcelead